January: 26.01.2026 – attention 17h15!
Prof. Jürgen Ruland (TUM School of Medicine and Health)
T-cell lymphomas: cancers fueled by hijacked immune resilience programs
Host: HD / Prof. Roers 

March: 02.03.2026
Prof. Johannes Huppa (Charité – Universitätsmedizin Berlin; DKTK – German Cancer Consortium Berlin; Max Delbrück Center for Molecular Medicine)
Understanding and engineering T-cell antigen recognition for the benefit of the cancer patient - insights from molecular imaging
Host: MA / Prof. Cerwenka

April: 13.04.2026
Prof. Tobias Bald (University Hospital Bonn)
AI-based protein design revolutionizing T cell-based immunotherapies
Host: HD / Prof. Roers 

June: 08.06.2026
Dr. Florian Wimmers (Department of Molecular Medicine, University of Tübingen)
From Patients to Organoids to AI: A Systems Biology Assessment of Vaccine Responses in Cancer
Host: HD / Prof. Roers

June: 25.06.2026 – exceptionally Thursday!
Dr. Dr. Mirco Friedrich (Hematology and Immune Engineering, DKFZ Heidelberg)
Engineering Immune Resilience to Target Cancer and Aging
Host: HD / Prof. Roers

July: 13.07.2026
Prof. Dr. Vigo Heissmeyer (Institute for Immunology, Biomedical Center LMU Ludwig-Maximilians-Universität München)
Control of T cell functions in autoimmunity and anti-tumor responses by RNA-binding proteins
Host: MA / Prof. Cerwenka und Prof. Stoecklin

September: 14.09.2026
Prof. Dr. Tak Wah Mak (Senior Scientist at the Princess Margaret Cancer Centre at University Health Network, Toronto, Canada; Professor at the Departments of Medical Biophysics & Immunology, University of Toronto, Canada; Scientific Co-Director at the Centre for Oncology & Immunology, Hong Kong Science Park, Hong Kong and Honorary Professor, Dept of Pathology, School of Clinical Medicine at the Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong)
Beyond Immune Checkpoint Blockade:  Emerging Strategies
Host: MA / Prof. Andreas Linkermann

October: 06.10.2026
Prof. Roger Geiger (Institute for Research in Biomedicine / IRB, USI Lugano)
Enhancing T cell responses against tumors
Host: HD / Prof. Roers

December: 02.12.2026 – attention Wednesday!
Henning Walcak, PhD (Alexander von Humboldt Professor of Biochemistry, Director, Institute of Biochemistry I  (IBC1), Medical Faculty – University of Cologne)
Non-canonical ubiquitin and death receptor–ligand systems in cell death, inflammation, infection and cancer
Host: HD / Prof. Roers